Phaseline

Companies › Cartesian Therapeutics

Cartesian Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 5 registered trials: 3 Phase 2, 1 Phase 3, 1 Phase 1; Neurology, Immunology, Other; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Descartes-08
Autologous T-cells expressing chimeric antigen receptor directed to BCMA
–Phase 3Myasthaenia Gravis; Myasthenia Gravis, Generalized; Systemic Lupus Erythematosus (SLE); Antisynthetase Syndrome …Dec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04146051Descartes-08Phase 2Myasthenia Gravis, GeneralizedNeurologyJan 2026
NCT06038474Descartes-08Phase 2Systemic Lupus Erythematosus (SLE)ImmunologyDec 2026
NCT06799247Descartes-08Phase 3Myasthaenia GravisNeurologyDec 2026
NCT07391605Descartes-08Phase 2Antisynthetase SyndromeOtherNov 2027
NCT07089121Descartes-08Phase 1Childhood-onset Systemic Lupus ErythematousImmunologyDec 2027

From the company's SEC filings

Cash of $123m on 2026-09-30; operating cash outflow about $95m a year; runway about 16 months at that burn, to Jan 2028; 3 of 3 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Private offerings reported to the SEC (Form D)

Specialist investors

Held by 2 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Laboratorios Silanes S.A. de C.V. COMPASS Pathways NervGen Pharma Alumis Immunic

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.